Literature DB >> 17084483

Distress screening in a multidisciplinary lung cancer clinic: prevalence and predictors of clinically significant distress.

Kristi D Graves1, Susanne M Arnold, Celia L Love, Kenneth L Kirsh, Pamela G Moore, Steven D Passik.   

Abstract

Screening for distress in cancer patients is recommended by the National Comprehensive Cancer Network, and a Distress Thermometer has previously been developed and empirically validated for this purpose. The present study sought to determine the rates and predictors of distress in a sample of patients being seen in a multidisciplinary lung cancer clinic. Consecutive patients (N=333) were recruited from an outpatient multidisciplinary lung cancer clinic to complete the Distress Thermometer, an associated Problem Symptom List, and two questions about interest in receiving help for symptoms. Over half (61.6%) of patients reported distress at a clinically significant level, and 22.5% of patients indicated interest in receiving help with their distress and/or symptoms. Problems in the areas of family relationships, emotional functioning, lack of information about diagnosis/treatment, physical functioning, and cognitive functioning were associated with higher reports of distress. Specific symptoms of depression, anxiety, pain and fatigue were most predictive of distress. Younger age was also associated with higher levels of distress. Distress was not associated with other clinical variables, including stage of illness or medical treatment approach. Similar results were obtained when individuals who had not yet received a definitive diagnosis of lung cancer (n=134) were excluded from analyses; however, family problems and anxiety were no longer predictive of distress. Screening for distress in a multidisciplinary lung cancer clinic is feasible and a significant number of patients can be expected to meet clinical criteria for distress. Results also highlight younger age and specific physical and psychosocial symptoms as predictive of clinically significant distress. Identification of the presence and predictors of distress are the first steps toward appropriate referral and treatment of symptoms and problems that contribute to cancer patients' distress.

Entities:  

Mesh:

Year:  2006        PMID: 17084483      PMCID: PMC1857305          DOI: 10.1016/j.lungcan.2006.10.001

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  46 in total

1.  Age-related differences in the quality of life of breast carcinoma patients after treatment.

Authors:  L B Wenzel; D L Fairclough; M J Brady; D Cella; K M Garrett; B C Kluhsman; L A Crane; A C Marcus
Journal:  Cancer       Date:  1999-11-01       Impact factor: 6.860

2.  Awareness and barriers to use of cancer support and information resources by HMO patients with breast, prostate, or colon cancer: patient and provider perspectives.

Authors:  E G Eakin; L A Strycker
Journal:  Psychooncology       Date:  2001 Mar-Apr       Impact factor: 3.894

3.  The prevalence of psychological distress by cancer site.

Authors:  J Zabora; K BrintzenhofeSzoc; B Curbow; C Hooker; S Piantadosi
Journal:  Psychooncology       Date:  2001 Jan-Feb       Impact factor: 3.894

4.  The first year after breast cancer diagnosis: hope and coping strategies as predictors of adjustment.

Authors:  Annette L Stanton; Sharon Danoff-Burg; Melissa E Huggins
Journal:  Psychooncology       Date:  2002 Mar-Apr       Impact factor: 3.894

5.  Resource use in women completing treatment for breast cancer.

Authors:  L Edgar; J Remmer; Z Rosberger; M A Fournier
Journal:  Psychooncology       Date:  2000 Sep-Oct       Impact factor: 3.894

6.  Predictors of depressive symptomatology of geriatric patients with lung cancer-a longitudinal analysis.

Authors:  M E Kurtz; J C Kurtz; M Stommel; C W Given; B Given
Journal:  Psychooncology       Date:  2002 Jan-Feb       Impact factor: 3.894

7.  Distress management. Clinical practice guidelines.

Authors: 
Journal:  J Natl Compr Canc Netw       Date:  2003-07       Impact factor: 11.908

8.  Assessment of psychological distress in prospective bone marrow transplant patients.

Authors:  P C Trask; A Paterson; M Riba; B Brines; K Griffith; P Parker; J Weick; P Steele; K Kyro; J Ferrara
Journal:  Bone Marrow Transplant       Date:  2002-06       Impact factor: 5.483

9.  Psychiatric morbidity and its recognition by doctors in patients with cancer.

Authors:  L Fallowfield; D Ratcliffe; V Jenkins; J Saul
Journal:  Br J Cancer       Date:  2001-04-20       Impact factor: 7.640

10.  How successful are oncologists in identifying patient distress, perceived social support, and need for psychosocial counselling?

Authors:  W Söllner; A DeVries; E Steixner; P Lukas; G Sprinzl; G Rumpold; S Maislinger
Journal:  Br J Cancer       Date:  2001-01       Impact factor: 7.640

View more
  99 in total

1.  Personal responsibility, regret, and medical stigma among individuals living with lung cancer.

Authors:  Kevin R Criswell; Jason E Owen; Andrea A Thornton; Annette L Stanton
Journal:  J Behav Med       Date:  2015-11-06

2.  Psychotropic drug initiation during the first diagnosis and the active treatment phase of B cell non-Hodgkin's lymphoma: a cohort study of the French national health insurance database.

Authors:  Cécile Conte; Manuela Rueter; Guy Laurent; Robert Bourrel; Maryse Lapeyre-Mestre; Fabien Despas
Journal:  Support Care Cancer       Date:  2016-07-19       Impact factor: 3.603

3.  Understanding the needs of lung cancer patients during the pre-diagnosis phase.

Authors:  David Wiljer; Tara Walton; Julie Gilbert; Amy Boucher; Peter M Ellis; Susan Schiff; Scott M Sellick; Marko Simunovic; Andrea Bezjak; Sara Urowitz
Journal:  J Cancer Educ       Date:  2012-06       Impact factor: 2.037

4.  Evaluation of a screening programme for psychological distress in cancer survivors.

Authors:  Gabriella Morasso; Silvia Di Leo; Anita Caruso; Andrea Decensi; Monica Beccaro; Laura Berretta; Laura Bongiorno; Maurizio Cosimelli; Stefania Finelli; Gabriella Rondanina; Wissya Santoni; Vittoria Stigliano; Massimo Costantini
Journal:  Support Care Cancer       Date:  2009-11-18       Impact factor: 3.603

5.  New lung cancer treatments (immunotherapy and targeted therapies) and their associations with depression and other psychological side effects as compared to chemotherapy.

Authors:  Daniel C McFarland
Journal:  Gen Hosp Psychiatry       Date:  2019-04-18       Impact factor: 3.238

6.  Translation and Evaluation of a Lung Cancer, Palliative Care Intervention for Community Practice.

Authors:  Huong Q Nguyen; Nora Ruel; Mayra Macias; Tami Borneman; Melissa Alian; Mark Becher; Kathy Lee; Betty Ferrell
Journal:  J Pain Symptom Manage       Date:  2018-08-02       Impact factor: 3.612

7.  IT-based Psychosocial Distress Screening in Patients with Sarcoma and Parental Caregivers via Disease-specific Online Social Media Communities.

Authors:  Florian Pohlig; Ulrich Lenze; Heinrich M L Muhlhofer; Florian W Lenze; Johannes Schauwecker; Carolin Knebel; Tanja Zimmermann; Peter Herschbach
Journal:  In Vivo       Date:  2017 May-Jun       Impact factor: 2.155

8.  Complementary and alternative medicine use among patients with thoracic malignancies.

Authors:  Rashmi S Bismark; Hongbin Chen; Grace K Dy; Elizabeth A Gage-Bouchard; Martin C Mahoney
Journal:  Support Care Cancer       Date:  2014-02-21       Impact factor: 3.603

9.  Cancer-Related Distress: Revisiting the Utility of the National Comprehensive Cancer Network Distress Thermometer Problem List in Women With Gynecologic Cancers.

Authors:  Patricia I Jewett; Deanna Teoh; Sue Petzel; Heewon Lee; Audrey Messelt; Jeffrey Kendall; Dorothy Hatsukami; Susan A Everson-Rose; Anne H Blaes; Rachel I Vogel
Journal:  JCO Oncol Pract       Date:  2020-02-24

10.  Effectiveness of an interdisciplinary palliative care intervention for family caregivers in lung cancer.

Authors:  Virginia Sun; Marcia Grant; Marianna Koczywas; Bonnie Freeman; Finly Zachariah; Rebecca Fujinami; Catherine Del Ferraro; Gwen Uman; Betty Ferrell
Journal:  Cancer       Date:  2015-07-06       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.